Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Flupenthixol--a partial atypical neuroleptic?].

K U Kühn1, K Meyer, W Maier

  • 1Klinik und Poliklinik für Psychiatrie und Psychotherapie Rheinische Friedrich-Wilhelms-Universität Bonn. k.u.kuehn@uni-bonn.de

Fortschritte Der Neurologie-Psychiatrie
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

B vitamin treatments modify the risk of myocardial infarction associated with a MTHFD1 polymorphism in patients with stable angina pectoris.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2016
Same author

Technical note: Genetic principal component models for multitrait single-step genomic evaluation.

Journal of animal science·2015
Same author

Uranium Hydridoborates: Synthesis, Magnetism, and X-ray/Neutron Diffraction Structures.

Inorganic chemistry·2015
Same author

Low-valent iron: an Fe(I) ate compound as a building block for a linear trinuclear Fe cluster.

Chemical communications (Cambridge, England)·2015
Same author

Loss of apoptosis-inducing factor critically affects MIA40 function.

Cell death & disease·2015
Same author

Estimating sampling error of evolutionary statistics based on genetic covariance matrices using maximum likelihood.

Journal of evolutionary biology·2015

Defining atypical neuroleptics remains challenging. Receptor-binding profiles, particularly combined D2/5-HT2 antagonism, offer the clearest distinction for these antipsychotic medications.

Area of Science:

  • Pharmacology
  • Neuroscience

Context:

  • The classification of neuroleptics into
  • typical
  • and
  • atypical
  • categories lacks a universally accepted definition.
  • Current definitions often rely on receptor-binding profiles and clinical outcomes, but these criteria can be ambiguous.

Purpose:

  • To critically evaluate the definitions of
  • atypical
  • neuroleptics based on receptor-binding characteristics and clinical efficacy.
  • To assess the classification of Flupentixol within the spectrum of typical and atypical neuroleptics.

Summary:

  • A precise definition of
  • atypical

Related Experiment Videos

  • neuroleptics is elusive.
  • The most reliable definition involves receptor-binding profiles, emphasizing combined D2 and 5-HT2 receptor antagonism, preferential D4/D3 receptor binding, and a balanced D2/D1 antagonism.
  • Clinical criteria, such as absence of extrapyramidal side effects (EPMS) and improvement in negative symptoms, are insufficient for clear differentiation, as some atypical agents can cause EPMS and lack consistent efficacy for negative symptoms.

    • Impact:

    • This analysis suggests that neuroleptics should be classified as
    • atypical
    • based on a favorable ratio of antipsychotic activity to EPMS and demonstrated efficacy in treating negative symptoms.
    • Flupentixol exhibits characteristics that warrant its classification as at least a
    • partial atypical neuroleptic
    • .